This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Altria's (MO) Q4 Earnings Coming Up: Factors Worth Noting
by Zacks Equity Research
Altria's (MO) fourth-quarter results are likely to reflect cigarette volume concerns, though strength in pricing and RRPs is likely to have been an upside.
Altria (MO) Stock Moves -0.02%: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $40.20, marking a -0.02% move from the previous day.
Earnings Preview: Altria (MO) Q4 Earnings Expected to Decline
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $39.93, marking a -1.26% move from the previous day.
Altria (MO) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Altria (MO) stood at $40.44, denoting a -0.74% change from the preceding trading day.
Altria (MO) Smoke-Free Strength Aids Amid Low Cigarette Volumes
by Zacks Equity Research
Altria (MO) is positioned for growth due to strategic pricing and a focus on smoke-free alternatives amid soft cigarette volumes.
Altria (MO) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Altria (MO) concluded the recent trading session at $41.34, signifying a -0.63% move from its prior day's close.
Altria (MO) Stock Moves -0.12%: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $41.86, moving -0.12% from the previous trading session.
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD
Q4 Earnings Season Scorecard and Research Reports for McDonald's, Walt Disney & Applied Materials
by Sheraz Mian
Today's Research Daily features an update on the Q4 earnings season and new analyst reports on McDonald's (MCD), Disney (DIS), Applied Materials (AMAT) and others.
Altria (MO) Stock Moves -0.43%: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Altria (MO) stood at $41.40, denoting a -0.43% change from the preceding trading day.
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPHD
Altria (MO) Positioned Well to Navigate Complexities in 2024
by Zacks Equity Research
Altria's (MO) strong pricing power and focus on smoke-free products have been providing some cushion against soft cigarette shipment volumes and the impacts of inflation.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) concluded the recent trading session at $40.18, signifying a -0.4% move from its prior day's close.
Altria (MO) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Altria (MO) stood at $40.31, denoting a +0.02% change from the preceding trading day.
Here's Why Altria (MO) Gained But Lagged the Market Today
by Zacks Equity Research
In the closing of the recent trading day, Altria (MO) stood at $42.11, denoting a +0.21% change from the preceding trading day.
Zacks Industry Outlook Highlights Philip Morris International, Altria Group and British American Tobacco
by Zacks Equity Research
Philip Morris International, Altria Group and British American Tobacco are part of the Zacks Industry Outlook article.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
3 Tobacco Stocks Hogging in the Limelight on Favorable Industry Trends
by Vrishali Bagree
The Zacks Tobacco industry companies are gaining on pricing power and smoke-free product strength amid soft cigarette volumes and cost inflation. Philip Morris (PM), Altria Group (MO) and British American Tobacco (BTI) look well-placed.
Altria's (MO) Pricing Power Aids Amid Soft Cigarette Volumes
by Zacks Equity Research
Altria Group (MO) looks well-positioned for growth due to its pricing power and focus on smoke-free products amid low cigarette volumes.
The Zacks Analyst Blog Highlights Exxon Mobil, Oracle, Cisco, Altria and CrowdStrike
by Zacks Equity Research
Exxon Mobil, Oracle, Cisco, Altria and CrowdStrike are included in this Analyst Blog.
Top Analyst Reports for Exxon Mobil, Oracle & Cisco Systems
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), Oracle Corporation (ORCL) and Cisco Systems, Inc. (CSCO).
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD